Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer.

MLA

Yi Rang Kim, et al. “Evaluation of Pemetrexed and Etoposide as Therapeutic Regimens for Human Papillomavirus-Positive Oral and Oropharyngeal Cancer.” PLoS ONE, vol. 13, no. 7, Jan. 2018, p. e0200509. EBSCOhost, https://doi.org/10.1371/journal.pone.0200509.

APA

Yi Rang Kim, Bada Lee, Mi Ran Byun, Jong Kil Lee, & Jin Woo Choi. (2018). Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer. PLoS ONE, 13(7), e0200509. https://doi.org/10.1371/journal.pone.0200509

Chicago

Yi Rang Kim, Bada Lee, Mi Ran Byun, Jong Kil Lee, and Jin Woo Choi. 2018. “Evaluation of Pemetrexed and Etoposide as Therapeutic Regimens for Human Papillomavirus-Positive Oral and Oropharyngeal Cancer.” PLoS ONE 13 (7): e0200509. doi:10.1371/journal.pone.0200509.